Jonathan Root - May 13, 2021 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Director
Signature
Dale Holladay, Attorney in Fact for the Reporting Person
Stock symbol
NARI
Transactions as of
May 13, 2021
Transactions value $
$0
Form type
4
Date filed
5/17/2021, 06:44 PM
Previous filing
Mar 18, 2022
Next filing
Jun 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Other -2.62M -100% 0 May 13, 2021 Directly owned by USVP X F1, F2
transaction NARI Common Stock Other -83.8K -100% 0 May 13, 2021 Directly owned by AFF X F1, F2
transaction NARI Common Stock Other +686K 686K May 13, 2021 Directly owned by PMG X F1, F3
transaction NARI Common Stock Other -686K -100% 0 May 13, 2021 Directly owned by PMG X F1, F4
transaction NARI Common Stock Other +94K +21.96% 522K May 13, 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro-rata in-kind distribution of the Issuer's common stock, and not a purchase or sale, without additional consideration to their respective partners, members and assignees, as applicable.
F2 Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates Fund L.P. ("AFF X" and, together with USVP X, the "USVP X Funds"), without additional consideration, to its partners. Presidio Management Group X, L.L.C. ("PMG X") is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the securities held by the USVP X Funds. The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to such shares, and deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds, and disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
F3 Represents a pro-rata in-kind distribution of the Issuer's common stock to PMG X from each of the USVP X Funds, without additional consideration. The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to the shares, and deemed to have sole voting and dispositive power over the reported securities held by PMG X, and disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
F4 Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by PMG X, without additional consideration to its members (the "PMG Distribution"). The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to the shares, and may be deemed to have sole voting and dispositive power over the reported securities held by PMG X, and disclaims beneficial ownership of such securities held by PMG X, except to the extent of any pecuniary interest therein.
F5 Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the PMG X Distribution. Shares are held directly by the Reporting Person.